We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.49B
AUM Growth
-$343M
Cap. Flow
-$249M
Cap. Flow %
-2.94%
Top 10 Hldgs %
16.07%
Holding
2,271
New
51
Increased
125
Reduced
935
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 17.14%
2 Financials 17.01%
3 Healthcare 12.77%
4 Industrials 11.29%
5 Consumer Discretionary 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAYN
1776
DELISTED
Haynes International, Inc.
HAYN
$247K ﹤0.01%
6,653
FRGI
1777
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$247K ﹤0.01%
13,371
PCSB
1778
DELISTED
PCSB Financial Corporation
PCSB
$247K ﹤0.01%
11,786
DNLI icon
1779
Denali Therapeutics
DNLI
$4.04B
$246K ﹤0.01%
+12,469
New +$256K
LRN icon
1780
Stride
LRN
$3.27B
$246K ﹤0.01%
17,337
TCX icon
1781
Tucows
TCX
$140M
$245K ﹤0.01%
4,376
HIBB
1782
DELISTED
Hibbett, Inc. Common Stock
HIBB
$245K ﹤0.01%
10,209
PGEM
1783
DELISTED
Ply Gem Holdings, Inc.
PGEM
$244K ﹤0.01%
11,295
NIC icon
1784
Nicolet Bankshares
NIC
$3.72B
$243K ﹤0.01%
4,410
RMR icon
1785
The RMR Group
RMR
$337M
$243K ﹤0.01%
3,481
GTHX
1786
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$242K ﹤0.01%
+6,532
New +$174K
HMHC
1787
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$242K ﹤0.01%
34,853
-13,960
-29% -$110K
NPK icon
1788
National Presto Industries
NPK
$998M
$241K ﹤0.01%
2,572
PGNX
1789
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$241K ﹤0.01%
32,263
FORR icon
1790
Forrester Research
FORR
$220M
$240K ﹤0.01%
5,782
JBSS icon
1791
John B. Sanfilippo & Son
JBSS
$989M
$240K ﹤0.01%
4,150
OMER icon
1792
Omeros
OMER
$992M
$240K ﹤0.01%
21,460
TG icon
1793
Tredegar Corp
TG
$281M
$240K ﹤0.01%
13,367
UCFC
1794
DELISTED
United Community Financial Corp
UCFC
$240K ﹤0.01%
24,319
TK icon
1795
Teekay
TK
$1.03B
$238K ﹤0.01%
29,414
+6,679
+29% +$57.7K
BOLD
1796
DELISTED
Audentes Therapeutics, Inc
BOLD
$238K ﹤0.01%
7,930
GOGO icon
1797
Gogo Inc
GOGO
$383M
$237K ﹤0.01%
27,419
MSBI icon
1798
Midland States Bancorp
MSBI
$696M
$237K ﹤0.01%
7,521
CTT
1799
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$237K ﹤0.01%
19,002
NSM
1800
DELISTED
Nationstar Mortgage Holdings
NSM
$237K ﹤0.01%
13,208

Similar funds

MetLife Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, MetLife Investment Management held 2,271 positions worth $8.49B, down 3.9% from $8.84B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q1 2018 filing shows 51 new, 125 increased, 935 reduced and 90 closed positions. Its largest new stake was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M. The largest sale was Bank of New York Mellon, an estimated $17.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2018 buy was Syneos Health, Inc. Class A Common Stock: 60,685 shares worth $2.15M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $25.3M increase.
  • MetLife Investment Management's biggest Q1 2018 reduction was Apple, cutting an estimated $10.6M.
  • MetLife Investment Management fully exited Bank of New York Mellon in Q1 2018, selling an estimated $17.1M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $8.49B portfolio in Q1 2018.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q1 2018.
  • MetLife Investment Management's portfolio value fell 3.9% quarter-over-quarter to $8.49B.

Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.